Literature DB >> 11229474

Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome.

Y Ozaki1, R Amakawa, T Ito, H Iwai, K Tajima, K Uehira, H Kagawa, Y Uemura, T Yamashita, S Fukuhara.   

Abstract

OBJECTIVE: We recently identified 3 fractions of human peripheral blood (PB) dendritic cells (DC), including the monocyte-associated fractions 1 and 2 (CD1a+,CD11c+ and CD1a-,CD11c+, respectively) and the lymphoid-associated fraction 3 (CD1a-,CD11c-). We attempted to determine whether these fractions were altered in Sjögren's syndrome (SS).
METHODS: We examined 23 patients with primary SS and 22 normal control subjects. DC were purified from PB and analyzed by flow cytometry. Immunohistochemical staining of labial salivary glands of SS patients was performed with monoclonal antibodies against fascin, which is known to be specific for DC.
RESULTS: The total numbers of PB DC and fraction 1 DC were decreased in SS. Immunohistochemical staining demonstrated that fascin+,CD11c+,HLA-DR+ mononuclear cells were present and scattered among numerous fascin-hyperfiltrating cells in SS patients. Interferon-gamma (IFNgamma)-producing Th1 cells were shown to be increased in both PB and salivary glands of patients, indicating the presence of general IFNgamma-producing Th1 polarization in SS. Furthermore, numbers of Thl cells were increased when naive T cells were cocultured with fraction 1 DC in vitro.
CONCLUSION: These findings suggest selective trafficking of fraction 1 DC into focal sites of inflammation and subsequent promotion of Th1 balance, suggesting a novel pathogenesis of SS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229474     DOI: 10.1002/1529-0131(200102)44:2<419::AID-ANR61>3.0.CO;2-U

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets.

Authors:  Kenichirou Tajima; Ryuichi Amakawa; Tomoki Ito; Michihiko Miyaji; Masashi Takebayashi; Shirou Fukuhara
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 2.  The oral component of Sjögren's syndrome: pass the scalpel and check the water.

Authors:  Ava J Wu
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 3.  Dendritic cells of the oral mucosa.

Authors:  A-H Hovav
Journal:  Mucosal Immunol       Date:  2013-06-12       Impact factor: 7.313

Review 4.  Contributions of Major Cell Populations to Sjögren's Syndrome.

Authors:  Richard Witas; Shivai Gupta; Cuong Q Nguyen
Journal:  J Clin Med       Date:  2020-09-22       Impact factor: 4.241

5.  Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjögren's syndrome but not in the maintenance.

Authors:  Y Ozaki; T Ito; Y Son; H Amuro; K Shimamoto; H Sugimoto; Y Katashiba; M Ogata; R Miyamoto; N Murakami; R Amakawa; S Fukuhara
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

6.  Involvement of dendritic cells in sarcoidosis.

Authors:  M Ota; R Amakawa; K Uehira; T Ito; Y Yagi; A Oshiro; Y Date; H Oyaizu; T Shigeki; Y Ozaki; K Yamaguchi; Y Uemura; S Yonezu; S Fukuhara
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

7.  Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome.

Authors:  Keiko Yoshimoto; Maiko Tanaka; Masako Kojima; Yumiko Setoyama; Hideto Kameda; Katsuya Suzuki; Kensei Tsuzaka; Yoko Ogawa; Kazuo Tsubota; Tohru Abe; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

8.  Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjögren's Syndrome.

Authors:  Donald U Stone; Dustin Fife; Michael Brown; Keith E Earley; Lida Radfar; C Erick Kaufman; David M Lewis; Nelson L Rhodus; Barbara M Segal; Daniel J Wallace; Michael H Weisman; Swamy Venuturupalli; Michael T Brennan; Christopher J Lessard; Courtney G Montgomery; R Hal Scofield; Kathy L Sivils; Astrid Rasmussen
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

Review 9.  Unique Phenotypes and Functions of Follicular Helper T Cells and Regulatory T Cells in Sjögren's Syndrome.

Authors:  Masako Saito; Kunihiro Otsuka; Aya Ushio; Akiko Yamada; Rieko Arakaki; Yasusei Kudo; Naozumi Ishimaru
Journal:  Curr Rheumatol Rev       Date:  2018

10.  MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1.

Authors:  Ana P Lopes; Joel A G van Roon; Sofie L M Blokland; Maojie Wang; Eleni Chouri; Sarita A Y Hartgring; Kim M G van der Wurff-Jacobs; Aike A Kruize; Boudewijn M T Burgering; Marzia Rossato; Timothy R D J Radstake; Maarten R Hillen
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.